Filtration devices and related methods thereof

• US 7,874,998 B2
• Filed: 11/06/2006
• Issued: 01/25/2011
• Est. Priority Date: 11/04/2005
• Status: Expired due to Fees

• Current Assignee: Board of Regents of the University of Michigan (University of Michigan)
• Original Assignee: Board of Regents of the University of Michigan (University of Michigan)
• Inventors: Brown, David L., Humes, H. David
• Primary Examiner(s): Deak; Leslie R
• Application Number:
  US11/593,270
• Publication Number:
  US 20080004712A1
• Time in Patent Office: 1,541 Days
• Field of Search: 604/4.01, 604/5.01, 604/5.04, 604/6.09, 604/6.11, 604/8, 604/9, 210/645, 210/646, 210/195.2, 210/321.79, 435/366, 435/369, 435/372, 435/400
• US Class Current: 604/5.04
• CPC Class Codes: A61M 1/1678 intracorporal peritoneal dialysis A61M1/28
• CPC Class Codes: A61M 1/28 Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation

Abstract

The present invention relates to filtration devices and related methods of use. In particular, the present invention relates to implantable filtration devices used, for example, for filtering impurities from a body fluid of a subject.

Claims

1. A method of treating renal failure in a subject, comprising:

(a) providing a device comprising (i) a housing defining at least one opening and (ii) a plurality of semi-permeable hollow fibers disposed within the housing; and

(b) positioning a tissue flap or an arteriovenous loop from the subject in the device through the opening so that the tissue flap or the arteriovenous loop forms a capillary bed within the housing that permits impurities in the blood of the subject to pass from the capillary bed and into the hollow fibers.

2. The method of claim 1 further comprising introducing into the device an exogenous growth factor for enhancing capillary bed formation within the housing.

3. The method of claim 1, wherein least one growth factor is selected from the group consisting of platelet-derived growth factors, vascular endothelial growth factors, and fibroblast growth factors.

4. The method of claim 1, wherein the arteriovenous loop is formed between a femoral artery and a femoral vein of the subject.

5. The method of claim 1 further comprising the step of implanting the device into the subject.

6. The method of claim 1, wherein the impurities flow into a reservoir in communication with the hollow fibers.